Skip to content

Opening book details…

About this Medicine article

4265 Pegfilgrastim on day 2 vs. day 4 within the prospective, multi- centered GAIN study: A phase III trial to compare ETC vs. EC-TX and ibandronate vs. observation in patients with node-positive primary breast cancer (GBG 33) by S. Loibl; B. Conrad; A. Schneeweiss; R. Kreienberg; E.F. Solomayer; M.R. Clemens; H. Tesch; V. Nekljudova; G. von Minckwitz; V. Möbus is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
S. Loibl; B. Conrad; A. Schneeweiss; R. Kreienberg; E.F. Solomayer; M.R. Clemens; H. Tesch; V. Nekljudova; G. von Minckwitz; V. Möbus
Publisher
Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 1359-6349)
Published
2009
Language
EN
Field
Medicine (Health Sciences)

More by S. Loibl; B. Conrad; A. Schneeweiss; R. Kreienberg; E.F. Solomayer; M.R. Clemens; H. Tesch; V. Nekljudova; G. von Minckwitz; V. Möbus

Browse all works by S. Loibl; B. Conrad; A. Schneeweiss; R. Kreienberg; E.F. Solomayer; M.R. Clemens; H. Tesch; V. Nekljudova; G. von Minckwitz; V. Möbus